UY31581A1 - Derivado 15, 16-metilen-17-(1' - propenil)-17-3' -oxidoestra-4-en-3-ona, su uso y medicamento que lo contiene - Google Patents
Derivado 15, 16-metilen-17-(1' - propenil)-17-3' -oxidoestra-4-en-3-ona, su uso y medicamento que lo contieneInfo
- Publication number
- UY31581A1 UY31581A1 UY31581A UY31581A UY31581A1 UY 31581 A1 UY31581 A1 UY 31581A1 UY 31581 A UY31581 A UY 31581A UY 31581 A UY31581 A UY 31581A UY 31581 A1 UY31581 A1 UY 31581A1
- Authority
- UY
- Uruguay
- Prior art keywords
- oxidoestra
- propenil
- methylen
- ona
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Derivados de 15,16-metilen-17-(1`-propenil) -17-3` -oxidestra-4-en -3 -ona que tienen la formula química general I , donde z se selecciona del grupo que comprende oxígeno, dos átomos de hidrogeno , NOR y NNHSO2R donde R es hidrogeno, C1-C10-alquilo o C7-C20-aralquilo, R4 se selecciona del grupo que comprende hidrogeno y halogeno.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007063496A DE102007063496A1 (de) | 2007-12-29 | 2007-12-29 | 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31581A1 true UY31581A1 (es) | 2009-08-03 |
Family
ID=40585540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY31581A UY31581A1 (es) | 2007-12-29 | 2008-12-26 | Derivado 15, 16-metilen-17-(1' - propenil)-17-3' -oxidoestra-4-en-3-ona, su uso y medicamento que lo contiene |
Country Status (24)
Country | Link |
---|---|
US (1) | US8623850B2 (es) |
EP (1) | EP2238148B1 (es) |
JP (1) | JP5600070B2 (es) |
KR (1) | KR20100110348A (es) |
CN (1) | CN101918427B (es) |
AR (1) | AR069963A1 (es) |
AU (1) | AU2008342915A1 (es) |
BR (1) | BRPI0821667A2 (es) |
CA (1) | CA2710486A1 (es) |
CL (1) | CL2008003921A1 (es) |
CO (1) | CO6321233A2 (es) |
CR (1) | CR11544A (es) |
DE (1) | DE102007063496A1 (es) |
DO (1) | DOP2010000202A (es) |
EA (1) | EA201001011A1 (es) |
EC (1) | ECSP10010317A (es) |
ES (1) | ES2397970T3 (es) |
IL (1) | IL206383A0 (es) |
PA (1) | PA8809801A1 (es) |
PE (1) | PE20091181A1 (es) |
TW (1) | TW200938205A (es) |
UY (1) | UY31581A1 (es) |
WO (1) | WO2009083271A1 (es) |
ZA (1) | ZA201005398B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012059594A1 (en) | 2010-11-04 | 2012-05-10 | Bayer Pharma Aktiengesellschaft | Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity |
TW201350122A (zh) * | 2012-04-23 | 2013-12-16 | Bayer Pharma AG | 18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內用途,包含18-甲基-15β,16β-亞甲基-19-降-20-螺氧-4-烯-3-酮的子宮內系統,及其於避孕及婦科治療之用途 |
CN110452279B (zh) * | 2019-05-13 | 2022-04-08 | 株洲千金药业股份有限公司 | 三萜类化合物和其药学上可接受的盐及制备方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1183500B (de) | 1962-10-12 | 1964-12-17 | Schering Ag | Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe |
US3705179A (en) | 1971-03-15 | 1972-12-05 | American Home Prod | Antiandrogenic steroids |
NL7701384A (nl) | 1977-02-10 | 1978-08-14 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks. |
DE2922500A1 (de) | 1979-05-31 | 1980-12-04 | Schering Ag | 6 beta .7 beta |
DE3402329A1 (de) | 1984-01-20 | 1985-08-01 | Schering AG, 1000 Berlin und 4709 Bergkamen | 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate |
DE3410880A1 (de) * | 1984-03-21 | 1985-10-03 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 17-substituierte estradiene und estratriene |
FR2598421B1 (fr) | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
DE3702383A1 (de) | 1987-01-23 | 1988-08-04 | Schering Ag | 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
JP2605041B2 (ja) * | 1987-05-30 | 1997-04-30 | 株式会社リコー | 感熱記録材料 |
DE19651000A1 (de) | 1996-12-01 | 1998-06-04 | Schering Ag | Oxyiminopregnancarbolactone |
DE102004063864A1 (de) | 2004-12-30 | 2006-07-13 | Schering Ag | 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate |
DE102006030416A1 (de) | 2006-06-29 | 2008-01-03 | Bayer Schering Pharma Ag | 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate |
-
2007
- 2007-12-29 DE DE102007063496A patent/DE102007063496A1/de not_active Withdrawn
-
2008
- 2008-12-23 CA CA2710486A patent/CA2710486A1/en not_active Abandoned
- 2008-12-23 CN CN2008801234199A patent/CN101918427B/zh not_active Expired - Fee Related
- 2008-12-23 KR KR1020107016943A patent/KR20100110348A/ko not_active Application Discontinuation
- 2008-12-23 BR BRPI0821667-3A patent/BRPI0821667A2/pt not_active IP Right Cessation
- 2008-12-23 WO PCT/EP2008/011164 patent/WO2009083271A1/de active Application Filing
- 2008-12-23 TW TW097150282A patent/TW200938205A/zh unknown
- 2008-12-23 EA EA201001011A patent/EA201001011A1/ru unknown
- 2008-12-23 PA PA20088809801A patent/PA8809801A1/es unknown
- 2008-12-23 AR ARP080105700A patent/AR069963A1/es unknown
- 2008-12-23 EP EP08866797A patent/EP2238148B1/de not_active Not-in-force
- 2008-12-23 JP JP2010540081A patent/JP5600070B2/ja not_active Expired - Fee Related
- 2008-12-23 AU AU2008342915A patent/AU2008342915A1/en not_active Abandoned
- 2008-12-23 US US12/810,857 patent/US8623850B2/en not_active Expired - Fee Related
- 2008-12-23 ES ES08866797T patent/ES2397970T3/es active Active
- 2008-12-26 UY UY31581A patent/UY31581A1/es not_active Application Discontinuation
- 2008-12-29 PE PE2008002190A patent/PE20091181A1/es not_active Application Discontinuation
- 2008-12-29 CL CL2008003921A patent/CL2008003921A1/es unknown
-
2010
- 2010-06-15 IL IL206383A patent/IL206383A0/en unknown
- 2010-06-29 EC EC2010010317A patent/ECSP10010317A/es unknown
- 2010-06-29 CR CR11544A patent/CR11544A/es not_active Application Discontinuation
- 2010-06-29 CO CO10078689A patent/CO6321233A2/es not_active Application Discontinuation
- 2010-06-29 DO DO2010000202A patent/DOP2010000202A/es unknown
- 2010-07-28 ZA ZA2010/05398A patent/ZA201005398B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR069963A1 (es) | 2010-03-03 |
EA201001011A1 (ru) | 2011-02-28 |
US8623850B2 (en) | 2014-01-07 |
IL206383A0 (en) | 2010-12-30 |
ZA201005398B (en) | 2012-12-27 |
DOP2010000202A (es) | 2010-07-31 |
CA2710486A1 (en) | 2009-07-09 |
CN101918427B (zh) | 2013-07-31 |
AU2008342915A1 (en) | 2009-07-09 |
KR20100110348A (ko) | 2010-10-12 |
CN101918427A (zh) | 2010-12-15 |
CO6321233A2 (es) | 2011-09-20 |
ECSP10010317A (es) | 2010-08-31 |
US20110003779A1 (en) | 2011-01-06 |
ES2397970T3 (es) | 2013-03-12 |
CR11544A (es) | 2010-08-27 |
JP2011507927A (ja) | 2011-03-10 |
PA8809801A1 (es) | 2009-07-23 |
JP5600070B2 (ja) | 2014-10-01 |
EP2238148A1 (de) | 2010-10-13 |
BRPI0821667A2 (pt) | 2015-06-16 |
DE102007063496A1 (de) | 2009-07-02 |
WO2009083271A1 (de) | 2009-07-09 |
EP2238148B1 (de) | 2012-10-24 |
TW200938205A (en) | 2009-09-16 |
CL2008003921A1 (es) | 2010-02-12 |
PE20091181A1 (es) | 2009-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY27807A1 (es) | Nuevos derivados de piridazin-3(2h)-ona | |
MX2009006877A (es) | Derivados indolicos con anillo unido en las posiciones 5,6 y metodos de uso de los mismos. | |
NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
HRP20110861T1 (hr) | Lijek za liječenje gripe | |
CL2008003593A1 (es) | Compuestos derivados de isoxazolo-piridazina; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de trastornos cognitivos como el alzheimer | |
SE0301700D0 (sv) | Novel compounds | |
ATE527253T1 (de) | Pyrimidin-substituierte benzimidazolderivate als proteinkinasehemmer | |
CL2003002731A1 (es) | Compuesto derivado de quinazolina de formula definida, que actua como inhibidor de la kinasa aurora; procedimiento de preparacion del compuesto; composicion farmaceutica que comprende al compuesto y uso del compuesto; util para el tratamiento de enfe | |
CU20100032A7 (es) | Depsipéptidos cíclicos | |
SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
UY29327A1 (es) | Derivados de n-(heteroaril)- 1 h- indol-2-carboxamidas, su preparacion y su aplicacion en terapeutica | |
CL2008003854A1 (es) | Compuestos derivados de 2-bencilpiridazinona, inhibidores, reguladores y/o moduladores de met-quinasa; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento de un tumor solido, de la sangre o del sistema inmune; kit farmaceutico que comprende una cantidad de dicho compuesto. | |
CY1110127T1 (el) | Υποκατεστημενες 1-προπιολυλο-πιπεραζινες με χημικη συγγενεια για τον υποδοχεα mglur5 για τη θεραπεια καταστασεων πονου | |
MEP8509A (en) | Combination treatment for diabetes mellitus | |
MA32776B1 (fr) | Inhibiteurs de l'akt et de la p70 s6 kinase | |
UA96277C2 (en) | Benzimidazole derivatives | |
ATE386534T1 (de) | Orale darreichungsform enthaltend probiotische bakterien | |
UA95715C2 (ru) | Фосфадиазиновые производные, фармацевтическая композиция и их применение | |
CL2008002689A1 (es) | Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia. | |
BRPI0512376A (pt) | piperazinodionas como antagonistas de receptor oxitocina | |
CR9182A (es) | Derivado de quinolina, su uso, preparacion y medicamento que lo contiene | |
WO2006097617A3 (fr) | Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux | |
CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
GT200600106A (es) | Agentes endoparasiticidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20171024 |